Our Team
Immune Foundry Labs was founded by two chemical engineers with deep expertise in biomaterials, drug delivery, and immunoengineering. Our founders are active faculty members at the University of North Carolina at Chapel Hill, where their academic research forms the scientific foundation of the company.
Co-Founder & CEO Prof. Eric Bachelder, Division of Pharmacoengineering and Molecular Pharmaceutics of Eshelman School of Pharmacy, UNC Chapel Hill. Expert in biomaterial design and immune engineering with a research program focused on immune tolerance and vaccine development
Co-Founder & Co-CEO Prof. Kristy Ainslie Eshelman Distinguished Professor; Director of Emerging Educational Programs in the Pharmaceutical Sciences; Professor, Department of Microbiology and Immunology; Professor, Joint Department of Biomedical Engineering, Eshelman School of Pharmacy, UNC Chapel Hill. Expert in pharmacoengineering, biomaterial development, and vaccine adjuvant research.
Our team combines rigorous academic training with an entrepreneurial drive to see our science make a real difference in patients’ lives. We are actively growing our team and building partnerships with scientists, clinicians, and industry leaders who share our vision.